Repeal of Regulation (EC) No 1829/2003 on the market of feed containing, consisting of and of food and feed products produced from genetically modified maize MON 810, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
This resolution expresses the European Parliament's objection to the European Commission's decision to renew the authorisation for placing genetically modified maize MON 810 on the market for food and feed. The decision affects consumers, farmers, and the environment by potentially allowing the continued use of maize MON 810, which is modified to produce insecticides (Bt toxins). The Parliament argues the decision exceeds the Commission's powers and is inconsistent with the aim of ensuring a high level of protection for human health, animal health, and the environment. The resolution calls for the repeal of the Commission's implementing decision, citing concerns about potential adverse effects of Bt toxins on human health and non-target organisms, and the lack of support from Member States.
Analysis
The European Parliament resolution addresses the renewal of authorisation for placing on the market of food and feed products derived from genetically modified maize MON 810.
What changes
- The resolution calls on the Commission to repeal Implementing Decision (EU) 2024/1828, which renewed the authorisation for genetically modified maize MON 810.
- The resolution considers that Implementing Decision (EU) 2024/1828 is not consistent with Union law, specifically Regulation (EC) No 1829/2003, regarding the aim of a high level of protection for human and animal health and the environment.
Expected impact
- The resolution states that Implementing Decision (EU) 2024/1828 exceeds the implementing powers provided for in Regulation (EC) No 1829/2003.
- The resolution considers that the authorisation decision is not compatible with the aim of Regulation (EC) No 1829/2003, which is to ensure a high level of protection for human life, health, animal health, welfare, and environmental and consumer interests.
- The resolution notes that the Commission continues to authorise GMOs despite objections from Parliament and a lack of qualified majority support from Member States.
Limitations
- The document is a European Parliament resolution and does not contain the full text of the Commission Implementing Decision (EU) 2024/1828, limiting the ability to analyze the specific details of the renewed authorisation.
- The document refers to previous resolutions and opinions but does not include their full content, which could provide further context for the current resolution's stance.
- Specific details regarding the 'adjuvant properties' of Bt toxins and their potential effects on the human immune system are mentioned but not elaborated upon within this text.
Shadow Rapporteurs
Some data sources haven't been updated in over 48 hours.